These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29217648)

  • 21. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
    J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
    Ui A; Yasui A
    Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.
    Kamezaki K; Luchsinger LL; Snoeck HW
    Exp Hematol; 2014 Mar; 42(3):192-203.e1. PubMed ID: 24269847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Yokoyama A
    Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.
    Van Belle S; El Ashkar S; Čermáková K; Matthijssens F; Goossens S; Canella A; Hodges CH; Christ F; De Rijck J; Van Vlierberghe P; Veverka V; Debyser Z
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia.
    Wan L; Wen H; Li Y; Lyu J; Xi Y; Hoshii T; Joseph JK; Wang X; Loh YE; Erb MA; Souza AL; Bradner JE; Shen L; Li W; Li H; Allis CD; Armstrong SA; Shi X
    Nature; 2017 Mar; 543(7644):265-269. PubMed ID: 28241141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells.
    Maethner E; Garcia-Cuellar MP; Breitinger C; Takacova S; Divoky V; Hess JL; Slany RK
    Cell Rep; 2013 May; 3(5):1553-66. PubMed ID: 23623499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
    Hsu CC; Shi J; Yuan C; Zhao D; Jiang S; Lyu J; Wang X; Li H; Wen H; Li W; Shi X
    Genes Dev; 2018 Jan; 32(1):58-69. PubMed ID: 29437725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis of novel benzimidazole derivatives as ENL inhibitors suppressing leukemia cells viability via downregulating the expression of MYC.
    Guo S; Jia T; Xu X; Yang F; Xiao S; Hou Z; Xu H; Ma S; Liu X; Luo C; Jiang H; Chen H; Chen S
    Eur J Med Chem; 2023 Feb; 248():115093. PubMed ID: 36645983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rtf1 is a multifunctional component of the Paf1 complex that regulates gene expression by directing cotranscriptional histone modification.
    Warner MH; Roinick KL; Arndt KM
    Mol Cell Biol; 2007 Sep; 27(17):6103-15. PubMed ID: 17576814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
    Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
    Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
    Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo.
    Takacova S; Slany R; Bartkova J; Stranecky V; Dolezel P; Luzna P; Bartek J; Divoky V
    Cancer Cell; 2012 Apr; 21(4):517-31. PubMed ID: 22516260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational and Thermodynamic Differences Underlying Wild-Type and Mutant Eleven-Nineteen-Leukemia YEATS Domain Specificity for Epigenetic Marks.
    Baweja L; Wereszczynski J
    J Chem Inf Model; 2023 Feb; 63(4):1229-1238. PubMed ID: 36786550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficiency of murine MLL-ENL-driven leukemia initiation changes with age and peaks during neonatal development.
    Okeyo-Owuor T; Li Y; Patel RM; Yang W; Casey EB; Cluster AS; Porter SN; Bryder D; Magee JA
    Blood Adv; 2019 Aug; 3(15):2388-2399. PubMed ID: 31405949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator.
    Schreiner SA; García-Cuéllar MP; Fey GH; Slany RK
    Leukemia; 1999 Oct; 13(10):1525-33. PubMed ID: 10516753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
    Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
    EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.